Talk:Kinin–kallikrein system

Untitled
I've found a nice long in-depth review (, also free as it happens) that I expect to be using to update this page... provided the wards are quiet tonight. JFW | T@lk  11:10, 8 May 2006 (UTC)


 * Another historical resource, but I have no access to it at present. JFW | T@lk  20:17, 29 June 2006 (UTC)

Risk of cardiovascular disease
JFW | T@lk  20:49, 5 July 2007 (UTC)

Review
Another recent review: JFW |  T@lk  09:10, 21 September 2007 (UTC)

Arcadian
... removed the following sources on which I initially based the article:
 * Dendorfer A, Wolfrum S, Dominiak P. Pharmacology and cardiovascular implications of the kinin-kallikrein system. Jpn J Pharmacol 1999;79:403-26..
 * Skidgel RA, Alhenc-Gelas F, Campbell WB. Relation of cardiovascular signaling by kinins and products of similar converting enzyme systems; prologue: kinins and related systems. New life for old discoveries. Am J Physiol Heart Circ Physiol 2003;284:H1886-91..

They might still be useful someday. JFW &#124; T@lk  20:01, 25 November 2010 (UTC)

New review
10.1111/jth.13194 JFW &#124; T@lk  09:29, 15 November 2015 (UTC)

What is ESR?
"Clinical symptoms include marked weakness, tachycardia, fever, leukocytosis and acceleration of ESR." But what is ESR?

DlronW (talk) 07:20, 1 October 2021 (UTC)